| Identification | Back Directory | [Name]
Dimetotiazine | [CAS]
7456-24-8 | [Synonyms]
8599RP
Fonazine
Bayer 1483
Dimethodin
Brn 0941549
Dimetotiazine
Dimetiotazine
Dimethiotazine
Dimetothiazine
Dimethothiazine
Dimetotiazine USP/EP/BP
13115-40-7 (Monomesylate)
3-Dimethylsulfonamido 10-(2-dimethylaminopropyl)phenothiazine
Dimethylsulfamido-3-(dimethylamino-2-propyl)-10-phenothiazine
10-[2-(Dimethylamino)propyl]-N,N-dimethylphenothiazine-2-sulfonamide
N,N-Dimethyl-10-[2-(dimethylamino)propyl]-10H-phenothiazine-2-sulfonamide
10H-Phenothiazine-2-sulfonamide, 10-[2-(dimethylamino)propyl]-N,N-dimethyl-
Phenothiazine-2-sulfonamide, 10-[2-(dimethylamino)propyl]-N,N-dimethyl- (6CI, 7CI, 8CI)
10-(2-dimethylaminopropyl)-N,N-dimethyl-phenothiazine-2-sulfonamide: m ethanesulfonic acid | [EINECS(EC#)]
231-229-6 | [Molecular Formula]
C19H25N3O2S2 | [MDL Number]
MFCD00868048 | [MOL File]
7456-24-8.mol | [Molecular Weight]
391.557 |
| Chemical Properties | Back Directory | [Boiling point ]
533.7±60.0 °C(Predicted) | [density ]
1.1822 (rough estimate) | [refractive index ]
1.6560 (estimate) | [pka]
8.91±0.50(Predicted) |
| Hazard Information | Back Directory | [Originator]
Migristene,Rhone Poulenc,France,1965 | [Uses]
Serotonin inhibitor. | [Definition]
ChEBI: Dimetotiazine is a member of phenothiazines. | [Manufacturing Process]
A solution of 3-dimethylsulfamoylphenthiazine (10 grams) in xylene (100 cc)
is heated under reflux for 3 hours with sodium amide (1.5 grams). A solution
of 1-dimethylamino-2-chloropropane (4.4 grams) in anhydrous xylene (30 cc)
is then added and heating under reflux continued for 4 hours. After cooling
the suspension obtained is agitated with water (50 cc) and ether (30 cc). The
aqueous layer is separated and the basic products are extracted from the
organic phase with 10% hydrochloric acid. The xylene layer is discarded and,
after the combined acid solutions have been made alkaline with sodium
carbonate, the base is extracted with chloroform. The chloroform solutions are
then washed with water and dried over anhydrous potassium carbonate. After
evaporation of the solvent under reduced pressure there is obtained a crude
resinous base (9.7 grams).
On the addition of ethereal hydrogen chloride to a solution of the base in
isopropanol and recrystallization from anhydrous ethanol of the salt formed,
there is obtained 3-dimethylsulfamoyl-10-(2-dimethylaminopropyl)
phenthiazine hydrochloride (2.1 grams), MP 214°C with decomposition. After
dissolving the product in anhydrous ethanol and adding methanesulfonic acid
there is obtained fonazine mesylate. | [in vivo]
Dimethothiazine (0.5-16 mg/kg; i.v.; single dosage) reduces decerebrate rigidity in cats[2]. | Animal Model: | Cats (decerebrate model; the carotid arteries were clamped and the mid-brain sectioned approximately between the colliculae)[2] | | Dosage: | 0.5, 1, 2, 4, 8 and 16 mg/kg | | Administration: | i.v.; single dosage | | Result: | Reduced the discharge frequency of primary and secondary endings at 1-4 mg/kg.
Reduced the sensitivity of the muscle spindle to stretch in preparations with intact ventral roots.
Reduced the activity of the dynamic fusimotor fibres. |
|
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
|